Madrigal Pharmaceuticals Announces $300+ Million In Financing Events To Advance Resmetirom Program
Amount Raised
$300 Million
Round Type
Funding Round
ConshohockenBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that it has raised $259 million in gross equity (or $255 million in net proceeds) from equity securities issuances and an additional $50 million in liquidity commitments following the achievement of the clinical milestone under its Hercules Credit Facility.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Madrigal Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
- CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
Who to call at Madrigal Pharmaceuticals, and when
A new round usually means Madrigal Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Madrigal Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Madrigal Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Madrigal Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Madrigal Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Madrigal Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.